Lead choice in cardiac implantable electronic devices: an Italian survey promoted by AIAC (Italian Association of Arrhythmias and Cardiac Pacing)
暂无分享,去创建一个
G. Boriani | M. Biffi | M. Ziacchi | F. Guerra | R. Ricci | R. De Ponti | M. Landolina | G. Stabile | G. Forleo | G. Zanotto | P. Palmisano | A. D'onofrio | M. Zoni Berisso | A. D’Onofrio
[1] C. Leclercq,et al. Cardiac resynchronization therapy non-responder to responder conversion rate in the more response to cardiac resynchronization therapy with MultiPoint Pacing (MORE-CRT MPP) study: results from Phase I. , 2019, European heart journal.
[2] C. Leclercq,et al. Rationale and design of a randomized clinical trial to assess the safety and efficacy of multipoint pacing therapy: MOre REsponse on Cardiac Resynchronization Therapy with MultiPoint Pacing (MORE‐CRT MPP–PHASE II) , 2019, American heart journal.
[3] G. Boriani,et al. [The Pacemaker and Implantable Cardioverter-Defibrillator Registry of the Italian Association of Arrhythmology and Cardiac Pacing - Annual report 2017]. , 2019, Giornale italiano di cardiologia.
[4] G. Boriani,et al. Cardiac resynchronization therapy: a comparison among left ventricular bipolar, quadripolar and active fixation leads , 2018, Scientific Reports.
[5] I. Nault,et al. Clinical performance of different DF‐4 implantable cardioverter defibrillator leads , 2018, Pacing and clinical electrophysiology : PACE.
[6] M. Leening,et al. Trends in replacement of pacemaker leads in the Netherlands: A long‐term nationwide follow‐up study , 2018, Pacing and clinical electrophysiology : PACE.
[7] G. Boriani,et al. Cardiac resynchronization therapy: How did consensus guidelines from Europe and the United States evolve in the last 15 years? , 2018, International journal of cardiology.
[8] G. Boriani,et al. Clinically oriented device programming in bradycardia patients: part 2 (atrioventricular blocks and neurally mediated syncope). Proposals from AIAC (Italian Association of Arrhythmology and Cardiac Pacing) , 2018, Journal of cardiovascular medicine.
[9] G. Boriani,et al. Clinically oriented device programming in bradycardia patients: part 1 (sinus node disease). Proposals from AIAC (Italian Association of Arrhythmology and Cardiac Pacing) , 2018, Journal of cardiovascular medicine.
[10] Paramdeep S. Dhillon,et al. Outcomes with single-coil versus dual-coil implantable cardioverter defibrillators: a meta-analysis , 2018, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[11] J. Baker,et al. Safety and Efficacy of Multipoint Pacing in Cardiac Resynchronization Therapy: The MultiPoint Pacing Trial. , 2017, JACC. Clinical electrophysiology.
[12] F. Leyva,et al. Cardiac Resynchronization Therapy Using Quadripolar Versus Non‐Quadripolar Left Ventricular Leads Programmed to Biventricular Pacing With Single‐Site Left Ventricular Pacing: Impact on Survival and Heart Failure Hospitalization , 2017, Journal of the American Heart Association.
[13] L. Di Biase,et al. Multipoint pacing via a quadripolar left-ventricular lead: preliminary results from the Italian registry on multipoint left-ventricular pacing in cardiac resynchronization therapy (IRON-MPP) , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[14] Ó. Cano,et al. Incidence and predictors of clinically relevant cardiac perforation associated with systematic implantation of active-fixation pacing and defibrillation leads: a single-centre experience with over 3800 implanted leads , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[15] Nigel Gupta,et al. Performance of Anatomically Designed Quadripolar Left Ventricular Leads: Results from the NAVIGATE X4 Clinical Trial , 2016, Journal of cardiovascular electrophysiology.
[16] Chance M. Witt,et al. Right atrial lead fixation type and lead position are associated with significant variation in complications , 2016, Journal of Interventional Cardiac Electrophysiology.
[17] Svein Færestrand,et al. Active fixation of a thin transvenous left-ventricular lead by a side helix facilitates targeted and stable placement in cardiac resynchronization therapy. , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[18] F. Prinzen,et al. Optimization of left ventricular pacing site plus multipoint pacing improves remodeling and clinical response to cardiac resynchronization therapy at 1 year. , 2016, Heart rhythm.
[19] David O. Martin,et al. Extraction of chronically implanted coronary sinus leads active fixation vs passive fixation leads. , 2016, Heart rhythm.
[20] G. Boriani,et al. Cardiac Resynchronization Therapy With a Quadripolar Electrode Lead Decreases Complications at 6 Months: Results of the MORE-CRT Randomized Trial. , 2016, JACC. Clinical electrophysiology.
[21] A. Curnis,et al. The novel active fixation coronary sinus lead: efficacy and safety of transvenous extraction procedure. , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[22] Andrea Mazzanti,et al. 2015 ESC Guidelines for the Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death. , 2016, Revista espanola de cardiologia.
[23] G. Boriani,et al. New left ventricular active fixation lead: The experience of lead extraction , 2015, Indian heart journal.
[24] M. Biffi,et al. Performance of a novel left ventricular lead with short bipolar spacing for cardiac resynchronization therapy: primary results of the Attain Performa quadripolar left ventricular lead study. , 2015, Heart rhythm.
[25] Shulin Wu,et al. A long-term, prospective, cohort study on the performance of right ventricular pacing leads: comparison of active-fixation with passive-fixation leads , 2015, Scientific Reports.
[26] D. Corrado,et al. Incidence, Management, and Prevention of Right Ventricular Perforation by Pacemaker and Implantable Cardioverter Defibrillator Leads , 2014, Pacing and clinical electrophysiology : PACE.
[27] A. Proclemer,et al. [The pacemaker and implantable cardioverter-defibrillator registry of the Italian Association Arrhythmology Cardiac Pacing and cardiac pacing - annual report 2013]. , 2014, Giornale italiano di cardiologia.
[28] J. Nielsen,et al. ESC Guidelines on cardiac pacing and cardiac resynchronization therapy , 2014 .
[29] A. Proclemer,et al. Preferred tools and techniques for implantation of cardiac electronic devices in Europe: results of the European Heart Rhythm Association survey. , 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[30] M. Bongiorni,et al. Learning while extracting: ‘pacing’ lessons from the world of lead extraction , 2013, Expert review of cardiovascular therapy.
[31] Lluís Mont,et al. 2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). , 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[32] Lluís Mont,et al. 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). , 2013, European heart journal.
[33] Giuseppe Boriani,et al. From lead management to implanted patient management: systematic review and meta-analysis of the last 15 years of experience in lead extraction , 2013, Expert review of medical devices.
[34] M. Zaccaria,et al. Rate, causes, and impact on patient outcome of implantable device complications requiring surgical revision: large population survey from two centres in Italy. , 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[35] K. Ellenbogen,et al. The Active Fixation Coronary Sinus Lead: More Peril than Promise? , 2012, Pacing and clinical electrophysiology : PACE.
[36] H. Burri,et al. Introduction of new industry standards for cardiac implantable electronic devices: balancing benefits and unexpected risks , 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[37] O. Wazni,et al. Active fixation mechanism complicates coronary sinus lead extraction and limits subsequent reimplantation targets , 2012, Journal of Interventional Cardiac Electrophysiology.